Delta-Fly Pharma, Inc. (TSE:4598) announced that it will issue 9,000 4th stock acquisition rights at a rice of ¥630 per right for gross proceeds of ¥5,670,000 on December 8, 2020. The transaction will include participation from Mizuho Securities Co., Ltd., Investment Arm. Each stock acquisition right is exercisable into 100 shares at an initial exercise price of ¥1,553 per share or at a minimum exercise price of ¥932 from December 25, 2020 to December 26, 2022. The company is issuing securities through third party allotment. The transaction has been approved by board of directors of the company. The transaction is expected to close on December 24, 2020.